EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Classic psychedelics, health behavior, and physical health

Otto Simonsson iD, Peter S Hendricks, Richard Chambers, Walter Osika, Simon B Goldberg

Therapeutic Advances in Psychopharmacology · 2022-01 · 12

DOI: 10.1177/20451253221135363 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Therapeutic Advances in Psychopharmacology, online erschienen am 30.11.2022. Verfasst von Otto Simonsson und 4 weiteren Autor:innen. Beteiligte Einrichtung: Center for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institute, Tomtebodavägen 18A, 171 77, Stockholm, Sweden. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCCIH NIH HHS, National Center for Complementary and Integrative Health, Three Springs Foundation through the Monash Centre for Consciousness & Contemplative Studies.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Preliminary evidence suggests that classic psychedelics may be effective in the treatment of some psychiatric disorders, yet little remains known about their effects on health behavior and physical health.

Objectives

The purpose of this study was to investigate associations of lifetime classic psychedelic use and psychological insight during one’s most insightful classic psychedelic experience with health behavior and physical health.

Methods

Using data representative of the US population with regard to sex, age, and ethnicity ( N = 2822), this study examined associations of lifetime classic psychedelic use and psychological insight with health behavior and physical health.

Results

Lifetime classic psychedelic use was associated with more healthy tobacco-related and diet-related behavior ( β = 0.05 and 0.09, respectively). Among lifetime classic psychedelic users ( n = 613), greater Psychological Insight Questionnaire (PIQ) total scale, PIQ Avoidance and Maladaptive Patterns (AMP) subscale, and PIQ Goals and Adaptive Patterns (GAP) subscale scores were each associated with higher odds of more healthy exercise-related behavior [adjusted odds ratios (aOR) (95% confidence interval, CI = 1.38 (1.13–1.68), 1.38 (1.13–1.68), and 1.32 (1.10–1.60), respectively] and higher odds of having a healthy body mass index (BMI) [aOR (95% CI) = 1.32 (1.07–1.63), 1.36 (1.10–1.69), and 1.23 (1.01–1.50), respectively], and greater GAP subscale scores were associated with more healthy diet-related behavior ( β = 0.10). All PIQ scales were positively associated with some health behavior improvements (overall, diet, exercise) attributed to respondents’ most insightful classic psychedelic experience ( β = 0.42, 0.18, and 0.17; β = 0.40, 0.19, and 0.17; and β = 0.40, 0.15, and 0.15, respectively), but only PIQ total scale and AMP subscale scores were positively associated with alcohol-related health behavior improvements ( β = 0.13 and 0.16, respectively).

Conclusion

Although these results cannot demonstrate causality, they suggest that psychological insight during a classic psychedelic experience may lead to positive health behavior change and better physical health in some domains, in particular in those related to weight management.

Schlagwörter

Stichwörter der Autor:innen

BMIbehaviorhealthpsilocybinpsychedelics

Autor:innen und Institutionen

  • Center for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institute, Tomtebodavägen 18A, 171 77, Stockholm, Sweden.
  • Department of Sociology, University of Oxford, Oxford, 42-43 Park End Street, OX1 1JD, UK.
  • Department of Health Behavior, School of Public Health, University of Alabama at Birmingham, 1665 University Boulevard, 35233, Birmingham, AL, USA.
  • Department of Health Behavior, School of Public Health, University of Alabama at Birmingham, Birmingham, AL, USA.
  • Monash Centre for Consciousness & Contemplative Studies, Monash University, Melbourne, VIC, Australia.
  • Center for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden.

ORCID-Profile: Otto Simonsson

Förderung

  • NCCIH NIH HHS
  • National Center for Complementary and Integrative Health
  • Three Springs Foundation through the Monash Centre for Consciousness & Contemplative Studies
  • the University of Alabama at Birmingham School of Public Health
  • Ekhagastiftelsen
  • Svenska Forskningsrådet Formas
  • Osmond Foundation

Zitieren

APA

Simonsson, O., Hendricks, P. S., Chambers, R., Osika, W., & Goldberg, S. B. (2022). Classic psychedelics, health behavior, and physical health. Therapeutic Advances in Psychopharmacology, 12. https://doi.org/10.1177/20451253221135363

Vancouver

Simonsson O, Hendricks PS, Chambers R, Osika W, Goldberg SB. Classic psychedelics, health behavior, and physical health. Therapeutic Advances in Psychopharmacology. 2022;12. doi:10.1177/20451253221135363

BibTeX
@article{Simonsson2022,
  author = {Simonsson, Otto and Hendricks, Peter S and Chambers, Richard and Osika, Walter and Goldberg, Simon B},
  title = {Classic psychedelics, health behavior, and physical health},
  journal = {Therapeutic Advances in Psychopharmacology},
  year = {2022},
  volume = {12},
  doi = {10.1177/20451253221135363}
}
Kostenlos starten →